Trial of Zolpidem for Sleep in Children with Autism

Trial ID or NCT#

NCT05540574

Status

recruiting iconRECRUITING

Purpose

The purpose of this study is to examine the effect of zolpidem on sleep in children and adolescents with Autism Spectrum Disorder (ASD). Zolpidem is a nonbenzodiazepine GABAa receptor agonist drug that acts as a hypnotic. To accomplish this, the investigators will use a randomized double-blind placebo-controlled crossover 8-week study design to examine the effect of zolpidem on sleep physiology as assessed by polysomnography (PSG), actigraphy, circadian rhythm, and clinical measures.

Official Title

Randomized Placebo-Controlled Crossover Trial of Zolpidem for Sleep in Children with Autism

Eligibility Criteria

Ages Eligible for Study: 8 Years to 17 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

Investigator(s)

Antonio Hardan, M.D.
Antonio Hardan, M.D.
Psychiatrist
Professor of Psychiatry and Behavioral Sciences

Contact us to find out if this trial is right for you.

Contact

Emma Baker, PhD
(650) 736-1235